Searchable abstracts of presentations at key conferences in endocrinology

ea0031p4 | Bone | SFEBES2013

Contribution to bone mass and strength of osteoblast GH actions that are independent of local IGF1 production: lessons from the SOCS2 knockout mouse

Dobie Ross , MacRae Vicky , Huesa Carmen , van't Hof Rob , Ahmed Faisal , Farquharson Colin

GH is anabolic to the skeleton but its mode of action is unclear. Clues are available from the study of the suppressor of cytokine signalling-2 (SOCS2) KO mouse which has increased bone mass despite normal systemic IGF1 levels. Whilst suggesting direct GH effects on bone forming osteoblasts the precise signalling mechanisms remain unclear. The aims of this study were, therefore, to further detail the bone phenotype of SOCS2 KO mice and determine if GH promotes bone mass by mec...

ea0034oc4.2 | Thyroid and bone | SFEBES2014

PHOSPHO1: roles beyond skeletal mineralisation

Oldknow Karla , Morton Nik , Yadav Manisha , Rajoanah Sophie , Huesa Carmen , Bunger Lutz , Ball Derek , Ferron Mathieu , Karsenty Gerard , MacRae Vicky , Luis Millan Jose , Farquharson Colin

Advances in genetic approaches to bone physiology have expanded our understanding of the mechanisms by which bone and energy homeostasis interact. PHOSPHO1, a bone specific phosphatase is essential for the initiation of bone mineralisation. Here we now show that Phospho1 ablation confers a remarkable protection against obesity and diabetes in mice. To understand the mechanism whereby Phospho1 impacts metabolism, microarray analysis of osteoblasts, the primary...